Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 15887955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design of ligands for the nicotinic acetylcholine receptors: the quest for selectivity.

  2004cited by this paper
• Mortality in relation to smoking: 50 years' observations on male British doctors

  2004cited by this paper
• A general route to the synthesis of 1,5-methano- and 1,5-ethano- 2,3,4,5-tetrahydro-1H-3-benzazepines.

  2004cited by this paper
• Preparation of 1,5-methano-2,3,4,5- tetrahydro-1H-3-benzazepine via Pd-catalyzed cyclization.

  2004cited by this paper
• Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization

  2004cited by this paper
• 3-D-QSAR of N-substituted 4-amino-3,3-dialkyl-2(3H)-furanone GABA receptor modulators using molecular field analysis and receptor surface modelling study.

  2004cited by this paper
• Nicotinic acetylcholine receptors as drug targets.

  2004cited by this paper
• Epibatidine structure-activity relationships.

  2004cited by this paper
• Estimates of global mortality attributable to smoking in 2000.

  2003cited by this paper
• SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.

  2003cited by this paper
• Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activities.

  2003cited by this paper
• Cytisine derivatives as high affinity nAChR ligands: synthesis and comparative molecular field analysis.

  2002cited by this paper
• Cellular mechanisms of nicotine addiction.

  2001cited by this paper
• Nicotine dependence: studies with a laboratory model.

  2001cited by this paper
• Synthesis of analogues of (-)-cytisine for in vivo studies of nicotinic receptors using positron emission tomography.

  2000cited by this paper
• Effects of the competitive nicotinic antagonist erysodine on behavior occasioned or maintained by nicotine: comparison with mecamylamine

  2000cited by this paper
• WHO Framework Convention on Tobacco Control: a global "good" for public health.

  2000cited by this paper
• Central nicotinic receptor ligands and pharmacophores.

  2000cited by this paper
• Role of dopamine in the behavioural actions of nicotine related to addiction.

  2000cited by this paper
• Blockade of nicotine self-administration with nicotinic antagonists in rats.

  1999cited by this paper
• Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy.

  1998cited by this paper
• Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine

  1998cited by this paper
• Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.

  1997cited by this paper
• Pharmacokinetic and Pharmacodynamic Principles of Illicit Drug Use and Treatment of Illicit Drug Users

  1997cited by this paper
• Neuronal nicotinic acetylcholine receptors as targets for drug discovery.

  1997cited by this paper
• Differential Reinforcing Effects of Cocaine and GBR-12909: Biochemical Evidence for Divergent Neuroadaptive Changes in the Mesolimbic Dopaminergic System

  1996cited by this paper
• Rational design of receptor partial agonists and possible mechanisms of receptor partial activation: a theory.

  1996cited by this paper
• Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities.

  1994cited by this paper
• Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain.

  1994cited by this paper
• Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit.

  1994cited by this paper
• Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

  1994cited by this paper
• Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.

  1993cited by this paper
• Electrophysiological recording from Xenopus oocytes.

  1992cited by this paper
• Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors

  1991cited by this paper
• Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline.

  1990cited by this paper
• The binding of L-[3H]nicotine to a single class of high affinity sites in rat brain membranes.

  1986cited by this paper
• Synthesis and pharmacological activity of 2,3,4,5,-tetrahydro-1,5-methano-1H-3-benzazepines.

  1979cited by this paper
• Synthesis and analgetic activity of 1,2,3,4,5,6-hexahydro-1,6-methano-3-benzozocines.

  1978cited by this paper
• [Cytisine (Tabex) as a pharmaceutical aid in stopping smoking].

  1971cited by this paper
• Some studies on cytisine and its methylated derivatives

  1969cited by this paper
• Experiments in the veratrole and quinoxaline groups.

  1947cited by this paper

• Synergistic effects of levo-tetrahydropalmatine and low-dose naltrexone on nicotine conditioned place preference in mice: a dual-target strategy based on dopamine and opioid systems

  2026cites this paper
• Rare coding variants in CHRNB3 associate with reduced daily cigarette smoking across ancestries

  2026cites this paper
• chrna3 Modulates Alcohol Response

  2025cites this paper
• Nicotine and neuronal nicotinic acetylcholine receptors: unraveling the mechanisms of nicotine addiction

  2025cites this paper
• Effect of varenicline on major adverse liver outcomes in alcohol‐associated liver disease: An exploratory analysis

  2025cites this paper
• Deciphering the Activation Mechanism and Internal Signaling Pathways of Dopamine Receptor D1 bound with Various Ligands via Molecular Simulations

  2025cites this paper
• Biphasic effect of nicotine on glutamatergic activity in male mouse brain.

  2025cites this paper
• Smoking cessation in India: A narrative review

  2025cites this paper
• Effects of varenicline as an adjunct to analgesic and anti-inflammatory therapy in acute nerve injury.

  2025cites this paper
• Nicotine replacement therapy: insights into the mechanisms and potential of nicotine receptor pathway.

  2025cites this paper
• Determinants of successful smoking cessation in outpatient settings: A comparative analysis of varenicline and free program interventions

  2025cites this paper
• Evaluating mediators of the effect of varenicline preloading on smoking abstinence in a randomized controlled trial.

  2025cites this paper
• Efficacy and safety of varenicline and bupropion, in combination and alone, for alcohol use disorder: a randomized, double-blind, placebo-controlled multicentre trial

  2025cites this paper
• Understanding varenicline function via key receptor and ligand interactions

  2025cites this paper
• Do lab-based assessments of pretreatment smoking reinforcement and cue-specific craving predict smoking cessation with varenicline?

  2025cites this paper
• Sex-Specific Mediation of Pre-Quit Smoking Reduction: Secondary Analysis of a Randomized Controlled Trial Extending Varenicline Preloading

  2025cites this paper
• The Effect of Varenicline on Smoking Cessation in Hospitalized Patients: A Systematic Review and Meta-Analysis

  2024cites this paper
• Roles of metabotropic signaling of nicotine receptors in the development and maintenance of nicotine reward through regulation of dopamine D3 receptor expression

  2024cites this paper
• Efficacy of bupropion and varenicline genetic markers in choosing pharmacological treatment for smoking cessation, and implications for combining drugs: A randomized controlled trial – GENTSMOKING

  2024cites this paper
• Seven-membered N-heterocycles as approved drugs and promising leads in medicinal chemistry as well as the metal-free domino access to their scaffolds.

  2024cites this paper
• Changes in distinct brain systems identified with fMRI during smoking cessation treatment with varenicline: a review

  2024cites this paper
• Individual variations in motives for nicotine self-administration in male rats: evidence in support for a precision psychopharmacology

  2024cites this paper
• The actions of varenicline on alkaloids from Conium maculatum (poison hemlock), Lupinus sulphureus (sulphur lupine) and Nicotiana glauca (tree tobacco).

  2024cites this paper
• A Systematic Review on Drugs Acting as Nicotinic Acetylcholine Receptor Agonists in the Treatment of Dementia

  2024cites this paper
• SR9883 is a novel small-molecule enhancer of α4β2* nicotinic acetylcholine receptor signaling that decreases intravenous nicotine self-administration in rats

  2024cites this paper
• Modulators of nicotine reward and reinforcement.

  2024cites this paper
• How is Membrane Permeation of Small Ionizable Molecules Affected by Protonation Kinetics?

  2024cites this paper
• [Perioperative smoking cessation (conventional smoking and e-cigarettes) in 2023. A narrative review of the literature].

  2024cites this paper
• Functions and pharmacology of α2β2 nicotinic acetylcholine receptors; in and out of the shadow of α4β2 nicotinic acetylcholine receptors.

  2024cites this paper
• Cytisine for smoking cessation: A 40-day treatment with an induction period

  2024cites this paper
• Documento de consenso sobre tabaquismo y riesgo vascular

  2024cites this paper
• Rhodium-Catalyzed Diastereoselective C-H Activation/[4 + 2] Annulation of α,β-Unsaturated Amides with Bicyclic Alkenes.

  2024cites this paper
• Molecular Pathogenesis, Organ Metastasis, and Targeted Therapy for Non-Small-Cell Lung Cancer.

  2024cites this paper
• An example of cytisine overdose with no consequent side-effects: a case report

  2024cites this paper
• Acetylcholine and Depression: Scrutinizing Future Therapeutic Targets for Novel Drug Development.

  2024cites this paper
• Exploring the Link between Altitude of Residence and Smoking Patterns in the United States

  2024cites this paper
• Identification of nicotine-seeking and avoiding larval zebrafish using a new three-choice behavioral assay

  2023cites this paper
• Construction of Bridged Benzazepines via Photo-Induced Dearomatization.

  2023cites this paper
• Nicotine receptor partial agonists for smoking cessation

  2023cites this paper
• Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders

  2023cites this paper
• Desensitizing nicotinic agents normalize tinnitus-related inhibitory dysfunction in the auditory cortex and ameliorate behavioral evidence of tinnitus

  2023cites this paper
• New medications development for smoking cessation

  2023cites this paper
• The Role of Microglia in Sex- and Region-Specific Blood-Brain Barrier Integrity During Nicotine Withdrawal

  2023cites this paper
• Varenicline Mitigates the Increased Risk of Pseudoarthrosis Associated with Nicotine.

  2023cites this paper
• Safety and efficacy of early varenicline prescription in hospitalized patients with acute myocardial infarction: East Asian population.

  2023cites this paper
• IUPHAR-review: The Integration of Classic Psychedelics into Current Substance Use Disorder Treatment Models.

  2023cites this paper
• Reduction of nicotine and ethanol intake in alcohol-preferring (UChB) female rats by the α4β2 nicotinic acetylcholine receptor partial agonists 5-bromocytisine and cytisine.

  2023cites this paper
• Bupropion Mediated Effects on Depression, Attention Deficit Hyperactivity Disorder, and Smoking Cessation.

  2023cites this paper
• Neuroimmune nexus in the pathophysiology and therapy of inflammatory disorders: role of α7 nicotinic acetylcholine receptors.

  2023cites this paper
• Gestational ethanol exposure impairs motor skills in female mice through dysregulated striatal dopamine and acetylcholine function

  2023cites this paper
• The role of nicotinic receptors in alcohol consumption.

  2023cites this paper
• Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

  2023cites this paper
• An integrated approach to pharmacotherapy in smoking cessation: the role of varenicline, bupropion, cytisine, and nicotine replacement therapy

  2023cites this paper
• Varenicline enhances recognition memory via α7 nicotinic acetylcholine receptors in the medial prefrontal cortex in male mice.

  2023cites this paper
• Nicotine Dependence among College Students Uninterested in Smoking Cessation during the COVID-19 Pandemic: A Cross-Sectional Survey

  2023cites this paper
• Good Practice Statements for the treatment of nicotine dependence

  2023cites this paper
• Obstructive Sleep Apnea and Smoking Increase the Risk of Cardiovascular Disease: Smoking Cessation Pharmacotherapy

  2023cites this paper
• Evaluation of the effectiveness of cytisine for the treatment of smoking cessation: A systematic review and meta-analysis.

  2023cites this paper
• First Episode of Psychosis in the Context of Varenicline Treatment for Smoking Cessation

  2023cites this paper
• Rapid Access to Chiral and Tripodal Cavitands from β‐Pinene

  2022cites this paper
• Neuroscientific Basis of Treatment for Substance Use Disorders.

  2022cites this paper
• Does Smoking Affect OSA? What about Smoking Cessation?

  2022cites this paper
• An inhibitory brainstem input to dopamine neurons encodes nicotine aversion.

  2022cites this paper
• Cytisine induced urticaria: a case report during a smoking cessation treatment

  2022cites this paper
• UFR2709, an Antagonist of Nicotinic Acetylcholine Receptors, Delays the Acquisition and Reduces Long-Term Ethanol Intake in Alcohol-Preferring UChB Bibulous Rats

  2022cites this paper
• The effect of Varenicline and Bupropion on smoking cessation: A network meta-analysis of 20 randomized controlled trials.

  2022cites this paper
• Simulation and Machine Learning Methods for Ion-Channel Structure Determination, Mechanistic Studies and Drug Design

  2022cites this paper
• Abrupt versus gradual smoking cessation with pre-cessation varenicline therapy for Chinese treatment-seeking smokers: A retrospective, observational, cohort study

  2022cites this paper
• Understanding the stimulus effects of nicotine and bupropion in a drug-drug discriminated goal-tracking task

  2022cites this paper
• Neurobiological Mechanisms of Nicotine Reward and Aversion

  2022influential citation
• Cytisine therapy improved smoking cessation in the randomized SMILE lung cancer screening trial.

  2022cites this paper
• Interactions between 2′-fluoro-(carbamoylpyridinyl)deschloroepibatidine analogues and acetylcholine-binding protein inform on potent antagonist activity against nicotinic receptors

  2022cites this paper
• A Phase I, Double-blind, Randomized, Placebo-controlled, Single Dose-escalation Study to Evaluate the Tolerability and Safety of Cytisinicline in Adult Smokers.

  2022cites this paper
• Non-nicotine constituents in cigarette smoke extract enhance nicotine addiction through monoamine oxidase A inhibition

  2022cites this paper
• Insights Into the Differential Desensitization of α4β2 Nicotinic Acetylcholine Receptor Isoforms Obtained With Positive Allosteric Modulation of Mutant Receptors

  2022cites this paper
• Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial

  2022cites this paper
• A virtual reality craving study in tobacco addiction: The role of non-pharmacological support in tobacco detox therapy

  2022influential citation
• Elucidating the reinforcing effects of nicotine: a tribute to Nadia Chaudhri

  2022cites this paper
• Effects of nicotine and lipopolysaccharide stimulation on adhesion molecules in human gingival endothelial cells

  2022cites this paper
• Evaluating Treatment Mechanisms of Varenicline: Mediation by Affect and Craving.

  2022cites this paper
• Comparing Smoking Cessation Interventions among Underserved Patients Referred for Lung Cancer Screening: A Pragmatic Trial Protocol.

  2021cites this paper
• Levo-tetrahydropalmatine inhibits α4β2 nicotinic receptor response to nicotine in cultured SH-EP1 cells

  2021cites this paper
• Detecting and classifying neurotransmitter signals from ultra-high sensitivity PET data: the future of molecular brain imaging

  2021cites this paper
• Novel Putative Positive Modulators of α4β2 nAChRs Potentiate Nicotine Reward-Related Behavior

  2021cites this paper
• Recent Developments In Novel Antidepressants Targeting Ô±4ÔÂ22-Nicotinic Acetylcholine Receptors

  2021cites this paper
• [Combinations of pharmacological treatments in smoking cessation. A systematic review].

  2021cites this paper
• Therapeutic concentrations of varenicline increases exocytotic release of catecholamines from human and rat adrenal chromaffin cells in the presence of nicotine.

  2021cites this paper
• Is cytisine contraindicated in smoking patients with coronary artery disease after percutaneous coronary intervention?

  2021cites this paper
• CYTISINE AND CYTISINE DERIVATIVES. MORE THAN SMOKING CESSATION AIDS.

  2021cites this paper
• Fluorescence activation mechanism and imaging of drug permeation with new sensors for smoking-cessation ligands

  2021cites this paper
• A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial)

  2021cites this paper
• Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy.

  2021cites this paper
• The effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials.

  2021cites this paper
• Short syntheses of 1-substituted dibenzothiophene derivatives.

  2021cites this paper
• A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol

  2021cites this paper
• Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial

  2021cites this paper
• Administration of N-acetylcysteine Plus Acetylsalicylic Acid Markedly Inhibits Nicotine Reinstatement Following Chronic Oral Nicotine Intake in Female Rats

  2021cites this paper
• Sex differences in COPD management

  2021cites this paper
• Functional alterations by a subgroup of neonicotinoid pesticides in human dopaminergic neurons

  2021cites this paper
• NDT_A_334403 3753..3768

  2021cites this paper